Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas

British Journal of Cancer

Volumn 82, Issue 6, 2000, Pages 1171-1176

  Iolascon, A ^a   Giordani, L ^a   Borriello, A ^d   Carbone, R ^a   Izzo, A ^a   Tonini, G P ^c   Gambini, C ^b   Della Ragione, F ^d  

^a UNIVERSITY OF BARI   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^d NONE

Author keywords

Neuroblastoma; TGF 1; TGF RI; TGF RII; TGF RIII

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER STAGING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034010649     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1058     Document Type: Article

References (35)

1. Bristow RE, Baldwin RL, Yamada SD, Kore M and Karlan BY (1999) Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer 85:658-668
2. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M and Hedborg F (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 8: 1466-1477
3. Chen C, Wang X-F and Sun LZ (1997) Expression of transforming growth factor β (TGFβ) type III restores automne TGFβ1 activity in human breast cancer MCF-7 cells. J Biol Chem 272: 12862-12867
4. Coffey RL, Kost LJ, Lyons RM, Moses HL and LaRusso NF (1987) Hepatic processing of transforming factor β in the rat. J Clin Invest 80: 750-757
5. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB and Thiele CJ (1995) Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res 55: 2380-2386
6. Filmus J and Kerbel RS (1993) Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Curr Opin Oncol 5: 123-129
7. Filmus J, Zhao J and Buick RN (1992) Overexpression of H-ras oncogene induces resistance to the growth inhibitory action of the transforming growth factor beta-1 (TGF-β1) and alters the number of TGF-β1 receptors in rat intestinal epithelial cell clones. Oncogene 7: 521-526
8. Fynan TM and Reiss M (1993) Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit Rev Onc 4: 493-540
9. Heldin CH, Miyazono K and Dijke P (1997) TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471
10. Hougaard S, Norgaard P, Abrahamsen N, Moses HL, Spang-Thomsen M and Skovgaard Poulsen H (1999) Inactivation of the transforming growth factor beta type II receptor in human cell lung cancer cell lines. Br J Cancer 79: 10065-1011
11. Iolascon A, Giordani L, Moretti A, Tonini GP, Lo Cunsolo C, Mastropietro S, Borriello A and Della Ragione F (1998a) Structural and functional analysis of cyclin dependent kinase inhibitor genes (CDKN2A, CDKN2B and CDKN2C) in neuroblastoma. Pediatr Res 43: 139-144
12. Iolascon A, Giordani L, Moretti A, Basso G, Borriello A and Della Ragione F (1998b) Analysis of CDKN2A, CDKN2B, CDKN2C and cyclin D genes status in hepatoblastoma. Hepatology 27: 989-995
13. Iolascon A, Lo Cunsolo C, Giordani L, Cusano R, Mazzocco K, Boumgartner M, Ghisellini P, Faienza MF, Boni L, De Bernardi B, Conte M, Romeo G and Tonini GP (1998c) Interstizial and large 1p deletion occurs in localized and disseminated neuroblastomas and predict an unfavorable outcome. Cancer Lett 130: 83-92
14. Johnson D, Lanahan A, Buck CR, Sehagal A, Morgan C, Mercer E, Bothwell M and Chao M (1986) Expression and structure of the human NGF receptor. Cell 47: 545-554
15. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S and George D (1994) Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA 91: 6002-6006
16. Kiefer MC, Stephans JC, Crawford K, Okino K and Barr PJ (1990) Ligand-affinity cloning and structure of a cell surface heparin sulfate protcoglycan that binds basic fibroblast growth factor. Proc Natl Acad Sci USA 87: 6985-6989
17. Kimchi A, Wang X-F, Weinberg RA, Cheifetz S and Massague J (1988) Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196-199
18. Lòpez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS and Massagué J (1991) Structure and expression of the membrane ptoteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67: 785-795
19. Lòpez-Casillas F, Wrana JL and Massagué J (1993) Betaglycan presents ligand to the TGFβ signaling receptor. Cell 73: 1435-1444
20. Lu S-L, Akiyama Y, Saitoh K and Yuasia Y (1995) Mutations of the transforming growth factor-β type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452-457
21. MacDonald RG, Pleffer SR, Coussens L, Tepper MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP and Ullrich A (1988) A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239: 1134-1137
22. Maniatis T, Fritsh E, Sambrook J (1990) Molecular cloning. In: Cold Spring Harbor Laboratory, A Laboratory Manual, pp. 7.6-7.22, 9.16-9.23. Cold Spring Harbor: New York
23. Markowitz S, Wang J, Myeroff L, Parson R, Sun L-Z, Lutterbugh J, Fan RS, Zborowska E, Vogelstein B, Brattain M and Wilson JKV (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338
24. Matoba H, Sagano S, Yamaguchi N and Miyachi Y (1998) Expression of transforming growth factor-beta 1 and transforming growth factor-beta type-II receptor mRNA in papillary thyroid carcinoma. Hormone Metab Res 30: 624-628
25. Morgan DD, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA and Rutter WJ (1987) Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329: 301-307
26. Pinkerton CR (1993) A clinical perspective in human neuroblastoma: recent advances in clinical and genetics analysis. In: Neuroblastoma in the 1990s, Schwab M, Tonin GP and Benard J (eds), pp. 3-10. Harwood Academic: Chur. Switzerland
27. Polyak K (1996) Negative regulation of cell growth by TGFβ. Biochim Biophys Acta 1242: 185-199
28. Radeke MJ, Misko TP, Hsu C, Herzenberg LA and Shooter EM (1987) Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325: 593-597
29. Royuela M, De Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile N and Paniagua R (1998) Transforming growth factor beta 1 and its receptor types I and II. Comparison in human prostate, benign prostatic hyperplasia and prostatic carcinoma. Growth Factors 16: 101-110
30. Saunders S, Jalkanen M, O'Farrell S and Bernfield M (1989) Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108: 1547-1556
31. Siegel SE and Sato JK (1986) Neuroblastoma. In: Oncology, Moossa AR, Robson MC and Schimpfl SC (eds), pp. 1211-1231. Williams and Wilkins: Baltimore
32. Sun LZ, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF and Brattain MG (1994) Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455
33. Wang X-F, Lin HY, Ng-Eaton E, Downward J, Ldish HF and Weinberg RA (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell 37: 797-805
34. Wang J, Han W, Zbrowska E, Liang J, Wang X, Willson JKV, Sun LZ and Brattain MG (1996) Reduced expression of transforming growth factor b type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271: 17366-17371
35. White RL (1998) Tumor suppressor pathways. Cell 92: 591-592